MedPath

Comparison of Epley Maneuver and Cinnarizine in Treatment of Benign Positional Paroxysmal Vertigo

Phase 3
Conditions
Benign Positional Paroxysmal Vertigo.
Benign paroxysmal vertigo
Registration Number
IRCT2016101717413N19
Lead Sponsor
Baqiyatallah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1- Patients with definite diagnosis of BPPV
2- only up to 2 days after diagnosis
3- those who have not received any treatments for BPPV

Exclusion criteria:
1- Patients with no definite diagnosis
2- those suspicious for other causes of vertigo, especially CNS involvement
3- not willing to participate
4- previous history of treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Positional Paroxysmal Vertigo. Timepoint: Before, first and second week after intervention. Method of measurement: Halpike test.;Symptom Resolution. Timepoint: First and second weeks after intervention. Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath